Macrophage Reprogramming with Anti-miR223-Loaded Artificial Protocells Enhances In Vivo Cancer Therapeutic Potential. (2022)

First Author: López-Cuevas P
Attributed to:  BrisEngBio: From Synthetic to Engineering Biology at Bristol funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/advs.202202717

PubMed Identifier: 36314048

Publication URI: http://europepmc.org/abstract/MED/36314048

Type: Journal Article/Review

Volume: 9

Parent Publication: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Issue: 35

ISSN: 2198-3844